Home › Psoriasis › North Carolina
Psoriasis clinical trials in North Carolina
3 studies for Psoriasis are looking for participants at sites in North Carolina.
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Revival Research Institute, LLC, Cary
- Onsite Clinical Solutions - Huntersville, Huntersville
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06857942A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 3, 2026 · NCT07654751Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Wilmington
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT07362017From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.